FangJie Liu

机构：Beijing VDJBio (China) · ORCID：0000-0002-3771-5566

发表论文 63 篇 · 总被引 394 次 · h-index 11

代表论文

Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial (2025 · EClinicalMedicine · 被引 10)
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial (2025 · Signal Transduction and Targeted Therapy · 被引 9)
Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067) (2024 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 9)
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial (2025 · EClinicalMedicine · 被引 4)
Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study (2025 · Nutrients · 被引 3)
Real-world disproportionality analysis of cardiac failure associated with novel antineoplastic agents in breast cancer: a pharmacovigilance study (2025 · Frontiers in Immunology · 被引 2)